Science Explorer Back to mapMap
Institution · MultiMedica

Most cited papers from MultiMedica

What are the most cited papers from MultiMedica?

The most cited paper from MultiMedica is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" (9,175) and "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (6,023).

Showing 50 of 59 papers. Every paper with more than 425 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk François Mach et al. · European Heart Journal Open access154 authors 31 Aug 2019 9,175
3 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
4 Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Brian A. Ference et al. · European Heart Journal Open access 8 Mar 2017 4,032
5 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Alberico Luigi Catapano et al. · European Heart Journal Open access120 authors 27 Aug 2016 3,212
6 Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Børge Grønne Nordestgaard et al. · European Heart Journal Open access 15 Aug 2013 2,797
7 TFOS DEWS II Diagnostic Methodology report James S. Wolffsohn, Reiko Arita, Robin L. Chalmers et al. · The Ocular Surface Jul 2017 2,152
8 Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity Robert R. Ross, Ian J. Neeland, Shizuya Yamashita et al. · Nature Reviews Endocrinology ReviewOpen access 4 Feb 2020 1,996
9 Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans Katherine Esposito, Francesco Nappo, Raffaele Marfella et al. · Circulation 14 Oct 2002 1,987
10 MicroRNA-133 controls cardiac hypertrophy Alessandra Carè et al. · Nature Medicine 29 Apr 2007 1,783
11 Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Jan Borén et al. · European Heart Journal Open access 8 Jan 2020 1,609
12 Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Erik S.G. Stroes et al. · European Heart Journal Open access 18 Feb 2015 1,451
13 Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement Florian Kronenberg et al. · European Heart Journal Open access 18 Aug 2022 1,443
14 Hypertension Suzanne Oparil, Maria Czarina Acelajado, George L. Bakris et al. · Nature Reviews Disease Primers ReviewOpen access 22 Mar 2018 1,172
15 Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications Elisa Dal Canto, Antonio Ceriello, Lars Rydén et al. · European Journal of Preventive Cardiology Open access 14 Nov 2019 1,023
16 The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities Désirée Bonci, Valeria Coppola, Maria Grazia Pia Musumeci et al. · Nature Medicine 19 Oct 2008 996
17 Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology Marco Ambrosetti et al. · European Journal of Preventive Cardiology Open access 30 Mar 2020 973
18 Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society Henry N. Ginsberg et al. · European Heart Journal Open access 30 Jul 2021 966
19 Global epidemiology of dyslipidaemias Angela Pirillo, Manuela Casula, Elena Olmastroni et al. · Nature Reviews Cardiology Review 8 Apr 2021 912
20 Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Albert Wiegman et al. · European Heart Journal Open access 25 May 2015 898
21 Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention Adriana Albini, Giuseppina Pennesi, Francesco Donatelli et al. · JNCI Journal of the National Cancer Institute Open access 11 Dec 2009 849
22 Distinct DNA methylomes of newborns and centenarians Holger Heyn et al. · Proceedings of the National Academy of Sciences Open access 11 Jun 2012 833
23 The tumour microenvironment as a target for chemoprevention Adriana Albini, Michael B. Sporn · Nature reviews. Cancer Review 12 Jan 2007 824
24 PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project Ming‐Sound Tsao et al. · Journal of Thoracic Oncology Open access 22 May 2018 820
25 Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol Kausik Kumar Ray, Harold Edward Bays, Alberico Luigi Catapano et al. · New England Journal of Medicine Open access 13 Mar 2019 815
26 EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study Kausik Kumar Ray et al. · European Journal of Preventive Cardiology Open access 28 Aug 2020 814
27 Continuous glucose monitoring and metrics for clinical trials: an international consensus statement Tadej Battelino et al. · The Lancet Diabetes & Endocrinology Open access 6 Dec 2022 811
28 Variation inPCSK9andHMGCRand Risk of Cardiovascular Disease and Diabetes Brian A. Ference, Jennifer G. Robinson, Robert D. Brook et al. · New England Journal of Medicine Open access 30 Nov 2016 793
29 Pulmonary hypertension in chronic lung disease and hypoxia Steven D. Nathan, Joan Albert Barberà, Seán Gaine et al. · European Respiratory Journal Open access 13 Dec 2018 785
30 LOX-1, OxLDL, and Atherosclerosis Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano · Mediators of Inflammation Open access 2013 784
31 Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Simon I Hay et al. · The Lancet Open access2,780 authors Oct 2025 762
32 High-Density Lipoprotein Subfractions - What the Clinicians Need to Know Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano · Cardiology 2013 747
33 Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper Bogdan Mateescu et al. · Journal of Extracellular Vesicles Open access 7 Mar 2017 737
34 Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease Brian A. Ference, John J.P. Kastelein, Kausik Kumar Ray et al. · JAMA Open access 29 Jan 2019 724
35 Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology Mariano Sanz, Antonio Ceriello, Martin Buysschaert et al. · Journal Of Clinical Periodontology Open access 24 Aug 2017 720
36 Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure Giuseppe Mancia, Rita Facchetti, Michele Bombelli et al. · Hypertension Open access 27 Mar 2006 696
37 The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease Zachary Scott Wallace et al. · Arthritis & Rheumatology Open access 2 Dec 2019 684
38 Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. Gabriele Missale, Roberto Bertoni, Vincenzo Lamonaca et al. · Journal of Clinical Investigation Open access Aug 1996 663
39 The Autonomic Nervous System and Hypertension Giuseppe Mancia, Guido M. Grassi · Circulation Research Open access 22 May 2014 632
40 Apolipoprotein B Particles and Cardiovascular Disease Allan D. Sniderman, George Thanassoulis, Tamara Glavinovic et al. · JAMA Cardiology Open access 23 Oct 2019 613
41 The Sympathetic Nervous System Alterations in Human Hypertension Guido M. Grassi, Allyn L. Mark, Murray Esler · Circulation Research Open access 12 Mar 2015 611
42 Safety of Statins Stefano Bellosta, Rodolfo Paoletti, Alberto Corsini · Circulation Open access 15 Jun 2004 580
43 A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee Andre Luis Moreira et al. · Journal of Thoracic Oncology Open access 17 Jun 2020 575
44 The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease Leonardo Elia, Manuela Quintavalle, Jiajun Zhang et al. · Cell Death and Differentiation Open access 9 Oct 2009 572
45 Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical Study Philip E.V. van Kerrebroeck, Anco C. van Voskuilen, John P.F.A. Heesakkers et al. · The Journal of Urology 18 Sep 2007 566
46 The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions Valentina Carlini, Douglas McClain Noonan, Eslam Abdalalem et al. · Frontiers in Immunology Open access 8 Jun 2023 540
47 Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? Luca Parisi, Elisabetta Gini, Denisa Baci et al. · Journal of Immunology Research Open access 2018 538
48 Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease Helena Gylling et al. · Atherosclerosis Open access 23 Nov 2013 527
49 Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Roberto Gennari, Sylvie Ménard, Francesco Fausto Fagnoni et al. · Clinical Cancer Research Open access Sep 2004 513
50 Impact of Lipids on Cardiovascular Health Brian A. Ference, Ian M Graham, Lale S Tokgözoğlu et al. · Journal of the American College of Cardiology Open access 27 Aug 2018 511

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.